Author:
Small David S.,Kothare Prajakti,Yuen Eunice,Lachno D. Richard,Li Ying G.,Winters Kenneth J.,Farid Nagy A.,Ni Lan,Jakubowski Joseph A.,Salazar Daniel E.,Thieu Vivian T.,Payne Christopher D.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference14 articles.
1. Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H (2000) The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties. Br J Pharmacol 129:1439–1446. doi: 10.1038/sj.bjp.0703237
2. Jakubowski JA, Winters KJ, Naganuma H, Wallentin L (2007) Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile. Cardiovasc Drug Rev 25:357–374. doi: 10.1111/j.1527-3466.2007.00027.x
3. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, for the TRITON-TIMI 38 Investigator (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001–2015. doi: 10.1056/NEJMoa0706482
4. Niitsu Y, Jakubowski JA, Sugidachi A, Asai F (2005) Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity. Semin Thromb Hemost 31:184–194. doi: 10.1055/s-2005-869524
5. Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, Jakubowski JA, Naganuma H, Winters KJ (2007) A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 153(66):e9–e16. doi: 10.1016/j.ahj.2006.10.1010
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献